ClinConnect ClinConnect Logo
Search / Trial NCT05720039

Robotic vs. Open NSM for Early Stage Breast Cancer

Launched by INTUITIVE SURGICAL · Jan 30, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Robotic Nsm Nipple Sparing Mastectomy Da Vinci Breast Cancer Mastectomy Breast Usa Robot Sp System Single Port

ClinConnect Summary

This clinical trial is looking at two different surgical methods for treating early-stage breast cancer in women: a robotic technique using the da Vinci SP Surgical System and a traditional open surgery called Nipple Sparing Mastectomy (NSM). The goal is to see which method is safer and more effective for women undergoing this type of surgery, which allows for the removal of breast tissue while preserving the nipple and can be followed by immediate breast reconstruction.

To be eligible for this trial, participants need to be women aged 21 or older with a body mass index (BMI) of less than 30 who are suitable candidates for the NSM procedure. They should have early-stage breast cancer and certain breast characteristics, such as a cup size of C or smaller. Unfortunately, women who have had previous breast surgery, certain types of breast cancer, or other specific health issues won't be able to participate. If you join the study, you can expect to undergo one of the two surgical procedures and will be monitored for safety and effectiveness afterward. This trial is currently recruiting participants, so there's an opportunity to contribute to important research while receiving care for breast cancer.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female age 21 or older
  • BMI \< 30
  • Candidate for an NSM procedure with immediate reconstruction
  • Diagnosis of early stage brest cancer
  • Breast ptosis ≤ Grade 2.
  • Cup size ≤ C.
  • Exclusion Criteria:
  • Previous breast surgery
  • Diagnosis of metastatic breast cancer
  • Prior radiation treatment to the chest
  • Current smokers
  • Contraindication for general anesthesia or surgery.
  • Known bleeding or clotting disorder.
  • Pregnant or suspected to be pregnant, or actively breastfeeding

About Intuitive Surgical

Intuitive Surgical is a leading innovator in robotic-assisted minimally invasive surgery, dedicated to enhancing surgical outcomes through advanced technology. Renowned for its da Vinci Surgical System, the company develops cutting-edge surgical platforms that empower healthcare professionals to perform complex procedures with precision and control. Committed to clinical excellence and patient safety, Intuitive Surgical actively sponsors clinical trials to advance the understanding and application of robotic surgery across various specialties, ultimately aiming to improve patient care and surgical results worldwide.

Locations

Seattle, Washington, United States

Duarte, California, United States

Durham, North Carolina, United States

Houston, Texas, United States

Jacksonville, Florida, United States

Philadelphia, Pennsylvania, United States

St. Louis, Missouri, United States

Evanston, Illinois, United States

Nashville, Tennessee, United States

Rochester, Minnesota, United States

Saint Louis, Missouri, United States

Atlanta, Georgia, United States

Lake Success, New York, United States

Los Angeles, California, United States

Detroit, Michigan, United States

Milwaukee, Wisconsin, United States

Irvine, California, United States

Evanston, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Madhu Gorrepati

Study Director

Intuitive

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials